Who
Kevin Michael Donahue
10% owner
Company insider
Files Form 4 as: 10% owner, Mainz Biomed.
In numbers
- Trades disclosed
- 4
- Buys
- 2
- Sells
- 0
- Bought
- $2.1M
- Sold
- $0
- Held for review
- 2 trades, left out of Bought and Sold
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Oct 2025
- Last trade
- 17 Oct 2025
- Last filed
- 20 Jan 2026
Companies traded
Activity over time
1 Oct 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Oct 2025filed 20 Jan 2026 | Mainz BiomedBiotechnology | SEC FORM 4 Bought | $1.0M685,000 at $1.51 | filing |
| 17 Oct 2025filed 20 Jan 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Bought | $1.0M685,000 at $1.51 | filing |
| 17 Oct 2025filed 16 Jan 2026 | Mainz BiomedBiotechnology | SEC FORM 4 Bought | held for review643,850 | filing |
| 17 Oct 2025filed 16 Jan 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Bought | held for review643,850 | filing |
News
No headline names them, or the companies they trade most, lately.